Pharmaceutical Giant AbbVie Makes a Major Bet on a New Immunotherapy, and Its Dividend Growth Record Attracts Income-Focused Investors Jul 1, 2026 Life Science
Anthropic Launches Claude Science to Enter Life Sciences, AI Drug Discovery Stocks Tumble in Response Jun 30, 2026 Life Science
Insiders Sell Nearly $900,000 in Stock as Monterosa Medical Faces Key Clinical Data Test Jun 29, 2026 Life Science
Innovative Pipeline Supports Long-Term Value, Moderna Still Has Upside After Doubling in Price Jun 26, 2026 Life Science
Merck KGaA’s $11.3 Billion Bio-Techne Buy Bolsters CGT Ambitions in Biggest Deal Since 2014 Jun 25, 2026 Life Science
Impressive Clinical Trial Data Drives Intellia Therapeutics Up 70% This Year Jun 25, 2026 Life Science
Mid-Cap Biotech Viking Therapeutics Could Emerge as a Potential Challenger to Eli Lilly and Novo Nordisk Jun 23, 2026 Life Science
Can Zumilokibart Become the Next Megablockbuster? Inside AbbVie’s $10.9 Billion Bet on Apogee Jun 22, 2026 Life Science
Why CRISPR Therapeutics Stock Is Stuck Despite Boasting the World’s First Approved CRISPR Therapy Jun 18, 2026 Life Science
Healthcare Expenditures Continue to Grow, Three Leading Stocks Lead the 2026 Investment Race Jun 16, 2026 Life Science
